Table 3.
Demographic characteristics of 6 individuals infected with HIV-1 with drug resistance mutation to RT inhibitors*
| ID | Group | Subtype | Drug resistance mutation | ||
|---|---|---|---|---|---|
| NNRTI | NRTI | Resistance | |||
| SM18 | CSW | CRF01_AE | K101E**E138G | RPV*** ETR | |
| UA6 | Hospital | CRF01_AE | K103N A98G | D67N K70R, M184V T215F K219Q | 3TC, AZT, TDF, NVP, EFV, ABC, d4T, FTC, ETR, RPV |
| IDU9 | IDU | CRF01_AE | E138A | RPV, ETR | |
| UA7 | Hospital | CRF01_AE | E138A | RPV, ETR | |
| UA15 | Hospital | CRF01_AE | V179D | RPV, ETR | |
| DN6 | Hospital | CRF01_AE | E138G | RPV, ETR | |
*HIV-1 drug resistance mutations were detected according to the International AIDS Society-USA panel and WHO surveillance list.
**Major drug resistance mutations are shown in bold.
***Highly resistant drugs are shown in bold.